Hepion Pharmaceuticals, Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2020 to 2023.
  • Hepion Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2024 was $0.000.
  • Hepion Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending March 31, 2024 was $0.000.
  • Hepion Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $0.000.
  • Hepion Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $0.000.
  • Hepion Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $0.000.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-04-10
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.